Are you an academic trainee (postdoc/PhD/MBA/MD/JD) interested in building life science startups? Are you passionate about therapeutics, diagnostics, medtech, or synthetic biology?
Register NOW for the Nucleate Summit!
About the Summit
The Nucleate Summit will be hosted in Boston, Massachusetts on August 29-30th, unifying the world’s largest biotech student community [registration + info here].
The two-day celebration will harness the potential of the Nucleate network from around the world, comprising hundreds of volunteers, founders, and investors. The Leadership Summit (Day 1) includes shared experiences that will strengthen bonds among Nucleate leadership, alumni, special guests, and sponsors. The Community Summit (Day 2) includes premier networking opportunities, inspirational speakers, and the Activator Pitch Showcase, featuring recent winners from the 9 Nucleate regions. Please read the descriptions of each ticket type and select the one that best fits your academic status, affiliation to Nucleate, and travel plans.
Attendance to the summit is completely free for all current academic trainees.
About Nucleate
Nucleate is a nonprofit organization dedicated to empowering the next generation of biotech leaders, with chapters spanning 9 regions and participation from over 70 academic institutions. Nucleate identifies future biotech entrepreneurs, removes barriers, and helps founders concentrate on building transformational technologies. Visit www.nucleate.xyz to learn more, and follow us on LinkedIn and Twitter.
Strong Track Record
Over four years, Nucleate has formed and supported 107 companies through our Activator program. Our alumni have gone on to raise over $160M in funding to develop technologies like protein sequencing (Glyphic), drug design (Manifold Bio), microbial fertilizer (Ivu Biologics) and biomanufacturing (Foray Biosciences). This year’s cohort has already raised $9M in capital – join us in August to learn more and network directly with our teams and community!
Published on August 19th, 2022
Last updated on August 19th, 2022